508.880.3700 MAIN OFFICE
508.977.2807 SALES & TRAINING
508.977.2803 HOLTER MONITORING
Building healthcare partnerships dedicated to developing clinically excellent heart and vascular programs that help practitioners detect and diagnose cardiovascular disease.
November 22, 2010 (MANCHESTER, CT) - Eastern Connecticut Health Network (ECHN) signs long-term agreement with NAVIX to operate and manage its non-invasive vascular lab program at two of its hospitals, Manchester Memorial Hospital and Rockville General Hospital.
"We realized the opportunity to expand our vascular services but lacked the clinical expertise to deliver the services our community demanded," said Kate Sims, VP of Operations. "NAVIX offered a complete program that met our timeline and high quality standards." ECHN will also expand community services to include NAVIX' risk-focused screening program. This screening program will help us identify and treat patients that have specific risk factors associated with stroke and vascular disease, but are most often asymptomatic.
September 10, 2010 (PLYMOUTH, MA) - NAVIX is pleased to announce that Jordan Hospital, an affiliate of Tufts Medical Center, has extended its long term agreement to use NAVIX for its non-invasive vascular ultrasound laboratory services. Since 1995, NAVIX has helped grow Jordan's patient volume by almost 400%, while improving the overall operational and clinical value of the lab. In addition to the contract extension, Jordan also chose NAVIX to provide ultrasound services to three additional locations for the hospital.
"Our NAVIX technologist has phenomenal customer service skills and consistently superior clinical expertise," says Donna Wencis, Director, Critical Care, Endoscopy and Respiratory Therapy. "She knows how to meet the needs of our physicians and is incredible with our patients!"
August 30, 2010 (TAUNTON, MA) - NAVIX Diagnostix, Inc., the leading outsourced cardiovascular diagnostic services provider in the northeastern United States, today announced a management-led recapitalization of the firm with private equity firm Prospect Partners, LLC, of Chicago, Ill.
"This is exciting news for NAVIX, our employees, and our clients," said Cheryl Ford, President and Chief Executive Officer. "We are delighted about this transaction and the confidence our new investment partners have shown in our management team and in the potential of our company. The institutional support will help further fuel the growth NAVIX has been experiencing, and will also allow us to invest more resources in our infrastructure and in our delivery programs in keeping with our emphasis on quality operations and patient care."
Since its inception in 1998, NAVIX Diagnostix has built a unique niche by partnering with healthcare providers to grow their non-invasive vascular labs. The company's programs help hospitals, multi-specialty practices, vascular surgeons, and cardiologists detect, diagnose, and manage peripheral vascular disease, a pre-cursor to strokes and coronary heart disease. NAVIX Diagnostix's services also include echocardiography and nuclear medicine.
To best assist its clients, NAVIX Diagnostix serves as a full-service lab partner. Its comprehensive offering includes staffing by highly credentialed technologists, ultrasound imaging and vascular testing equipment, vascular laboratory accreditation, physician education, risk-focused screening programs, and market development to help build and expand vascular lab practices. The company also has developed proprietary tools that can help clients improve their economic returns by providing high-quality service and standardized treatment protocols while operating in an accredited environment. NAVIX Diagnostix has more accredited labs than any other healthcare provider in the United States, and its clients stretch across nine states in New England and the mid Atlantic.
For Prospect Partners, which invests opportunistically in unique small companies in niche manufacturing, distribution, and service markets, NAVIX Diagnostix represents an exciting opportunity within a growing specialty healthcare services industry segment.
"NAVIX has established its leadership position in the outsourced cardiovascular diagnostic services market by developing proprietary clinical protocols and providing turnkey accreditation and delivery solutions that help clients build effective and profitable vascular labs," said Maneesh Chawla, a Principal at Prospect Partners. "We look forward to supporting the company's continued success by pursuing further organic growth, expanding its geographic footprint, and acquiring other companies that provide related products and services."
NAVIX Diagnostix will continue to be led by its current management team, which includes Ms. Ford; Michael Nikosey, Chief Financial Officer; Steve Flieder, Chief Operating Officer and Bob Kane, Senior VP - Clinical Services and Business Development.
Prospect Partners is an experienced investor in specialty healthcare service companies. The firm's related investments include prior platforms Marina Medical Billing, Inc., a provider of medical billing services to emergency room and anesthesiology groups, and Remuda Ranch Company, a provider of behavioral health care services to females suffering from eating disorders. Both companies were recapitalized with management and outside financial buyers in 2006.
About NAVIX Diagnostix, Inc.
NAVIX Diagnostix is a full-service outsource provider of cardiovascular diagnostic services to hospitals and multi-speciality, cardiology and vascular surgery physician practices. The company services over 100 clients across nine states in New England and the mid Atlantic, including some of the most prestigious academic medical and teaching hospitals, providing care to over 100,000 patients annually. For more information, visit www.navixdiagnostix.com.
Prospect Partners, of Chicago, Ill., is a leading private equity firm investing in smaller lower-middle-market companies, managing $470 million in three funds. Since its inception in 1998, Prospect Partners has invested nationwide in nearly 80 companies within a broad range of niche manufacturing, distribution, and specialty service markets. For more information, visit http://www.prospect-partners.com/.
June 15,2010 (TAUNTON, MA) - NAVIX Diagnostix, Inc and Medipattern Corporation, a pioneer in the development of medical software solutions, is pleased to announce their joint efforts to create Visualize:Vascular(TM) for 3D review of vascular ultrasound images. The Visualize:Vascular(TM) series was included in the "case of the day" reviews displayed by NAVIX at its booth at the 2010 Annual Vascular Meeting held in Boston, MA. "Visualize:Vascular is unique in that both the visualization of the vessel and its contents can potentially have broad application in vascular treatment options," commented Robert Kane, Senior Vice President of Business and Clinical Development for NAVIX Diagnostix. "We believe that vascular clinicians including surgeons, radiologists, and cardiologists will benefit from using Visualize to understand the complete vessel."
Medipattern and NAVIX Diagnostix have worked closely together to collect vascular data under Internal Review Board (IRB) monitoring in support of their research and development efforts in the vascular market. The Visualize:Vascular software is Medipattern's first product developed for the vascular market, which represents 35 percent of the overall ultrasound imaging market.
"Through vessel segmentation and 3D rendering, Visualize shows clinicians a view of ultrasound imaging from a holistic perspective: for example the entire carotid artery which is the pipeline to the brain, is reconstructed in 3D and can be viewed from any angle. Prior to Visualize, ultrasound images were displayed as separate slices with no 3D capability. Visualize enables us to see the morphology of the artery as well as the structure within the artery walls, thickening and blockages," comments Angela Rodriguez-Wong, MD, RVT from NAVIX Diagnostix. "Understanding the type and structure of the blockage will enable clinicians to better plan patient treatment."
"Medipattern plans to first develop 3D visualization of carotid arteries," states Jeff Collins, president and CEO of Medipattern. "This information will guide us as we develop the product and submit it for FDA certification later this year." Collins continues, "NAVIX Diagnostix has been instrumental in providing clinical expertise throughout the product development cycle. Once FDA approved, NAVIX Diagnostix plans to install Visualize in its vascular labs certified by the Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL). NAVIX Diagnostix is committed to superb patient care through adherence to the highest standards of patient care and to leading edge technology speeding accurate diagnosis."
April 12,2010 (JERSEY CITY, NJ) - Jersey City Medical Center opened its Vascular Lab services today utilizing NAVIX Diagnostix for all aspects of the service, including staffing, equipment, ICAVL accreditation and market development. Jersey City Medical Center realized that it needed a higher level of vascular ultrasound service than was otherwise available, and turned to NAVIX to provide a comprehensive solution to the problem. "The local community lacked a world class location that could provide expert diagnostic evaluation for patients suffering from peripheral vascular disease," commented Nathaniel Holmes, M.D. "and NAVIX clearly had both the clinical expertise and business strength to help us deliver excellent service and create the needed awareness for our community."
February 26,2010 (NEW HAVEN, CT) - Yale-New Haven Hospital's Advanced Vascular Imaging Services opened recently and offers advanced technology and expertise in diagnosing patients with vascular disease. NAVIX Diagnostix has been working with Yale since the fall of 2009 to create an extensive library of vascular ultrasound clinical protocols and train Yale Sonographers on the consistent and proficient use of these advanced imaging techniques. The Advanced Vascular Imaging Services offers a full range of vascular ultrasound exams, including abdominal aortic aneurysm and venous, arterial and cerebrovascular evaluations for inpatients and outpatients. Renal, dialysis access site and vein mapping exams are also available. These advanced studies are offered at key YNHH locations including the main campus, Long Wharf and the Shoreline medical building in Guilford, CT. Implementation teams have worked for several months to design, develop and staff the labs and to market these services throughout the region.
January 4,2010 (TAUNTON, MA) - NAVIX Diagnostix today announced that it signed 16 new Vascular Lab & Cardiovascular Diagostic contracts with hospitals, cardiology and vascular surgery practices in the northeast in 2009. NAVIX now manages over 150 sites for its clients across 9 states. "I am pleased that so many new clients have selected NAVIX as their vascular lab partner," said Cheryl Ford, President & Chief Executive Officer. "There are an estimated 8 - 12 million Americans with peripheral vascular disease. The country's aging population combined with an ever increasing number of at-risk patients creates an enormous need for hospitals and physicians to provide access to advanced diagnostics for their patients. We have been able to demonstrate to our partners that we can meet that need by providing superior care through a clinical pathway driven by NAVIX' unique clinical protocol options resulting in industry leading diagnostic capabilities." NAVIX Diagnostix' success is a result of a management team of seasoned healthcare executives and technologists focused exclusively on providing unparalleled service to its clients and clinical excellence for all of its patients.
October 5,2009 (NEEDHAM, MA) - Beth Israel Deaconess Hospital in Needham, MA began operating its general and vascular ultrasound labs with NAVIX Diagnostix today. Beth Israel was looking for a partner that could scale to meet the volume and quality demands of both its patients and physicians. Don Holmes, Director of Imaging, noted "We were well aware of NAVIX' reputation for consistent high quality staff, and a proven market development program to help us continue to grow our ultrasound services for the community." The long term agreement will provide for extended hours for both general and vascular diagnostics at the BI Needham campus, and includes the provision of Philips iU22 imaging equipment, ICAVL & AIUM accreditation, and market development services to grow Beth Israel Medical Center's ultrasound service line.
August 24,2009 (NEW HAVEN, CT) - Yale-New Haven Hospital has contracted with NAVIX to bring the company's non-invasive vascular lab program to its main campus in New Haven and select outpatient medical centers. The agreement between Yale-New Haven and NAVIX is designed to improve the ability of the hospital's Heart & Vascular Center to identify and treat patients at-risk for peripheral vascular disease. NAVIX will work with Yale-New Haven and their physicians, technologists & administration to educate the hospital's referring physician community & patient population, and increase the geographic footprint for vital vascular diagnostic services. NAVIX continues to assist hospitals and physician practices expand and improve their level of quality patient care.
June 26,2009 (TAUNTON, MA) - NAVIX Diagnostix started four new non-invasive vascular ultrasound labs in the past 30 days across New England, including cardiology practices, vascular surgery and multispecialty clinics. Cardiology Associates of Norwich Connecticut opened a vascular lab to complement their existing echocardiography and nuclear cardiology services. Goodman Vein & Laser Center turned to NAVIX for the company's ability to deliver high quality results and satisfy the accreditation requirements for payor reimbursement, and Grove Hill Medical Center vascular surgeons opened a vascular lab in two locations to deliver a higher level of service for their patients. These new clients saw the value of NAVIX' superior clinical protocols along with ICAVL accreditation necessary to provide vascular ultrasound imaging services for their patients.
May 11,2009 (TAUNTON, MA) - NAVIX Diagnostix, the Northeast's leader in cardiovascular outsourced solutions, today announced the signing of five new clients in April, consisting of long term agreements across New England and the Midatlantic states. The combined value of accreditation services, imaging excellence, and a unique approach to service needs has yielded a significant increase in client engagements for the company. These most recent additions to NAVIX' growing portfolio include a physician vascular surgery practice, cardiology practices and large multispecialty clinics. As payors continue to increase quality requirements via accreditation as well as technologist & interpreting physician credentialing, NAVIX Diagnostix is well positioned to take advantage of an increasing need for full-service cardiovascular services.
April 13, 2009 (TAUNTON, MA) - The Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL) informed NAVIX Diagnostix it has received accreditation for several of its clients. With NAVIX' services, clients are able to operate an ICAVL accredited vascular lab in as little as 60 days after commencement of services. With several payors requiring ICAVL accreditation and appropriately credentialed vascular ultrasound technologists as a pre-requisite for reimbursement, more practices and hospitals are turning to outsourcing solutions such as NAVIX to meet their needs. "ICAVL requires a significant investment in vascular imaging consistency & quality, and NAVIX' technologist hiring, training and delivery system provides exceptionally high level of sensitivity and specificity, and has proven reproducible across our client base" commented Lois Scheffler, Director of Clinical Services for NAVIX. Often requiring up to 1,000 hours of effort for the initial accreditation, NAVIX has developed a rigorous and thorough process for the accumulation, review and correlation of study data needed for submission. For more information on the accreditation process and requirements, visit http://www.icavl.org
March 10, 2009 (BROOKLINE, MA) - NAVIX Diagnostix, in conjunction with Lown Cardiovascular, has opened a non-invasive vascular lab. The group of cardiologists at Lown wanted a company that could provide more than just equipment and a vascular technologist. "We wanted a company that focused on quality, and had a passion for patient care," stated Dr. Vikas Saini - President, Lown Cardiovascular Research Foundation. "NAVIX' comprehensive exam protocols and ability to scale to meet our growth objectives were key factors in our decision to work with the company." NAVIX will also be securing ICAVL accreditation for the lab, and working with the local community to help educate referring physicians in the identification and treatment of peripheral vascular disease. Lown Cardiovascular was named for Dr. Bernard Lown, a Nobel Peace prize recipient, founder of the Lown Cardiovascular Research Foundation and a co-founder of the International Physicians for the Prevention of Nuclear War.
February 23, 2009 (STRATFORD, NJ) - University of Medicine & Dentistry has contracted with NAVIX to provide a full-service non-invasive vascular lab at two of their South Jersey campuses. Helen Gault, Manager of the Department of Surgery said, "NAVIX brings expertise to the University, enabling us to continue to deliver the high level of patient care that our community expects, while providing better economics for UMDNJ system." NAVIX will work with UMDNJ to secure ICAVL accreditation as well as educate the local referring physician community. The lab's medical director, Dr. Vincent DiGiovanni, a vascular surgeon for UMDNJ added, "Utilizing NAVIX is an excellent decision as it allows UMDNJ to increase the geographic footprint for vital diagnostic services, and expand a consistent level of care throughout our multiple locations." NAVIX continues to add prestigious universities to their growing list of cardiovascular clients.
February 20, 2009 (CAMDEN, NJ) - NAVIX has entered into an agreement with Cooper University to open non-invasive vascular labs in two strategic locations. Joel Bryers, Administrative Director, Department of Surgery commented, "Our vascular surgeons requested we investigate using NAVIX Diagnostix for providing a complete non-invasive vascular lab program for the University, and our evaluation showed that NAVIX labs have a reputation amongst university clients for providing the best in patient care, while providing flexibility in the operational models we could choose." The relationship between NAVIX and Cooper University will provide ICAVL accreditation, market development and expansion options to assist Cooper in increasing their geographic reach to the surrounding community. Dr. Joseph Lombardi, one of Cooper's newest surgeons added, "I've worked with NAVIX in another university setting and it was simply 'second nature' wanting to bring the same quality to Cooper University. NAVIX provides excellent care to patients and provides me with comprehensive information allowing me to better diagnose and treat my patients. I'm thrilled to be working with NAVIX at Cooper University!"
January 26, 2009 (CONCORD, MA) - Emerson Hospital opened a full-service, non-invasive vascular lab at their main campus in Concord, MA today, partnering with NAVIX to provide a comprehensive solution for the identification and treatment of patients at risk for peripheral vascular disease. NAVIX will manage Emerson's new dedicated vascular lab, and will roll out a risk-focused screening program to the community within the next few months. Patty Smith, Imaging Director for Emerson Hospital noted, "We chose NAVIX based upon their reputation for high quality work, as well as their proven ability to market & grow vascular lab services within a local referring physician community." Dr. Mark Connaughton, an Interventional Radiologist at Emerson added, "As a clinician I depend on vascular ultrasound for many of my patients diagnoses. NAVIX has a solid reputation for detailed and comprehensive vascular ultrasound studies and will provide Emerson with a world-class ICAVL accredited lab."
December 23, 2008 (TAUNTON, MA) - Several new clients have opened a non-invasive vascular lab with NAVIX Diagnostix over the past few months. Thoracic & Vascular Associates of Southern New Hampshire recently opened a Vein Center in Portsmouth, NH and chose NAVIX to perform venous reflux studies for vein ablation candidates. NAVIX' vascular lab program provided comprehensive reflux evaluation, as well as marketing of the vein center to the local referring physician community. Also joining the growing list of NAVIX vascular lab clients were Dr. Charanjit Rao, vascular surgeon in the Worcester area; Mystic Cardiology in Medford, MA; and Family Doctors, a Swampscott-based practice which sees close to 40,000 patient visits annually.
December 18, 2008 (WASHINGTON, DC) - NAVIX Diagnostix, Inc. has been selected for the 2008 Best of Taunton Award in the Doctors Equipment & Supplies category by the U.S. Local Business Association (USLBA).
The USLBA "Best of Local Business" Award Program recognizes outstanding local businesses throughout the country. Each year, the USLBA identifies companies that they believe have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of small business through service to their customers and community.
Various sources of information were gathered and analyzed to choose the winners in each category. The 2008 USLBA Award Program focused on quality, not quantity. Winners are determined based on the information gathered both internally by the USLBA and data provided by third parties.
U.S. Local Business Association (USLBA) is a Washington D.C. based organization funded by local businesses operating in towns, large and small, across America. The purpose of USLBA is to promote local business through public relations, marketing and advertising.
The USLBA was established to recognize the best of local businesses in their community. Our organization works exclusively with local business owners, trade groups, professional associations, chambers of commerce and other business advertising and marketing groups. Our mission is to be an advocate for small and medium size businesses and business entrepreneurs across America.
SOURCE: U.S. Local Business Association
U.S. Local Business Association
October 3, 2008 (PHILADELPHIA, PA) - Today, Albert Einstein Healthcare Network entered into a second long term agreement with NAVIX Diagnostix to provide a full-service vascular ultrasound laboratory to support wound care at Albert Einstein's Center for Wound Healing, located at the Tabor Road facility, adjacent to the main campus. According to Bob Kane, Sr. Vice President of Clinical Services for NAVIX, "Albert Einstein's wound care center realized that it needed a higher level of vascular ultrasound service than was otherwise available, and turned to NAVIX to provide a comprehensive solution to the problem." NAVIX non-invasive vascular ultrasound laboratory programs support several wound care programs, including The Center for Advanced Wound Healing at St. Francis Hospital and Medical Center in Hartford, CT.
September 8, 2008 (PHILADELPHIA, PA) - Albert Einstein Healthcare Network has entered into a long term agreement with NAVIX Diagnostix to provide a cardiovascular center in one of its newest and largest cardiology practices. Ms. Susan Bernini, Chief Operating Officer for Albert Einstein Healthcare commented, "We were impressed with NAVIX' approach and proven success in developing strategic partnerships to provide a high-quality, comprehensive scope of cardiovascular services for patient and physician communities. NAVIX provides an unusually high level of service, including expert staff and state-of-the-art equipment, and a passion for delivering superior patient care in an economically challenging environment." The NAVIX agreement includes equipment, staffing and business development activities which will reach out to Einstein community physicians and educate them on the scope and location of patient services.
The Einstein Healthcare Network consists of 1,237 inpatient beds and several outpatient centers throughout the greater Philadelphia area. The Healthcare Network, which includes Albert Einstein Medical Center, a 440-bed tertiary care teaching hospital, encompasses approximately 32,000 inpatient admissions, 75,000 emergency room visits and 255,000 ambulatory visits per year.
August 14, 2008 (TAUNTON, MA): - NAVIX Diagnostix announced today several cardiovascular lab accreditation updates. In all, NAVIX received notice from the Intersocietal Commissions for the Accreditation of Vascular Laboratories (ICAVL) and Nuclear Medicine Laboratories (ICANL) that accreditation was granted for nine (9) cardiovascular labs. Of particular note was ICAVL accreditation for NAVIX' mobile vascular laboratories. The mobile ICAVL granting allows new NAVIX clients operating a part-time lab to be ICAVL accredited almost immediately, utilizing NAVIX' proprietary clinical protocols. According to Dr. Leon Josephs, NAVIX' medical director for the mobile labs, "This granting was the result of significant effort, including hundreds of hours of work by NAVIX management and technologists to achieve the level of quality required by the ICAVL organization." NAVIX includes accreditation in a majority of client engagements, providing the necessary efforts to help their clients achieve what is quickly becoming a minimum standard in the industry. Often requiring up to 1,000 hours of effort for the initial accreditation, NAVIX has developed a rigorous and thorough process for the accumulation, review and correlation of study data needed for submission. For more information on the accreditation process and requirements, visit www.icavl.org (vascular), www.icanl.org (nuclear medicine) and www.icael.org (echocardiography).
June 13, 2008 (SAN DIEGO, CA): - The Society of Vascular Ultrasound (SVU) announced today that Joseph P. Hughes, RVT, RVS, FSVU, et al NAVIX Diagnostix, Inc., Taunton, MA, has been awarded the Oral Clinical Presentation Award for the presentation on "Risk Focused Screenings for Vascular Disease: One University Hospital's Experience". Each year, several papers are presented at the annual conference, this year having been held in San Diego, CA. NAVIX' risk focused screenings have identified over 25% of program participants with some form of peripheral arterial disease warranting further follow-up by a physician. The 30 minute screening is a painless non-invasive screening for carotid artery disease, abdominal aortic aneurysm and peripheral arterial disease and can save the life of an at-risk individual. Joseph P. Hughes, Assistant Vice President for Clinical Services at NAVIX noted "by screening an 'at-risk' population, we are more likely to find individuals in need of treatment than in some other screening programs offered nationwide." Some programs simply take all comers, regardless of age or risk factors, often resulting in far less than 5% of individuals in need of further follow up care.
May 27, 2008 (PHILADELPHIA, PA): - Chestnut Hill Hospital, a 180 bed acute care hospital and member of the 132 hospital CHS system, began outsourcing its vascular ultrasound lab today, to Vascular Diagnostics Center (VDC), a NAVIX Diagnostix managed affiliate. Chestnut Hill Hospital determined the expertise provided by NAVIX was necessary to improve overall community health and facilitate the accurate and expeditious diagnosis of patients suffering from peripheral arterial disease. With over 2,000 studies performed annually, VDC will seek ICAVL accreditation and to improve the vascular lab's profitability, delivering high quality, efficient patient care. Mike Nussbaum, Regional Sale Manager for NAVIX commented, "It was clear when we first met with the senior leadership at Chestnut Hill Hospital that they saw value, both in terms of economic and clinical benefits by outsourcing to NAVIX. The surgical, clinical and administrative staff worked closely with NAVIX to transition the services from in-house to outsourcing within less than a one-week period."
January 9, 2008 (PROVIDENCE RI): - NAVIX continues to fuel top line growth, adding several new clients. When University Surgical Associates, the largest vascular surgery practice in Rhode Island needed to gear up volume in their vascular lab, they turned to NAVIX Diagnostix to provide staff & equipment. Within two weeks of contracting with NAVIX, the company was able to provide a registered vascular technologist (RVT) and ultrasound equipment on a 10 hour, 4 day-per-week schedule. University Surgeons are also having their patients seen at NAVIX' newly opened Atwood Cardiovascular Services Center in nearby Johnston, RI, providing same day services for University Surgical patients in the Johnston area.
September 10, 2007 (AUNTMINNIE.COM): - A recent auntminnie.com article comments on the value of ultrasound screening programs. The article entitled Screening opportunities boost ultrasound prospects" on September 10th, 2007 by Erik Ridley states that "Increased interest in screening examinations and early identification of disease offer an opportunity for expanded use of ultrasound," according to Dr. Edward Bluth of Ochsner Clinic Foundation in New Orleans. In recent years, increasing attention has been paid by the lay press on healthcare issues and, in particular, the value of early disease identification and the role of screening, Bluth said. As a result, a better-informed public has been demanding greater participation in their healthcare decisions, and requesting screening examinations for early identification of disease. Another trend looming over the next year or two is the publics understanding of the increasing amount of radiation exposure they're facing from radiographic screening examinations, he said. The role of ultrasound as a safe screening tool is just now being appreciated in the press. Possible screening tests with ultrasound currently include AAA screening, carotid stenosis screening, and ankle-brachial index (ABI) for peripheral vascular disease, Bluth said.
August 13, 2007 (TAUNTON, MA): - NAVIX' Vascular Early Detection Initiative (VEDI TM) results has exceeded expectations! In an analysis of two VEDI TM programs deployed in May of this year, NAVIX has found that these risk-focused, routine screenings have identified over 25% of program participants with some form of peripheral arterial disease warranting further follow-up by a physician. The 20 minute screening is a painless non-invasive screening for carotid artery disease, abdominal aorta aneurysm and peripheral arterial disease and can save the life of an at-risk individual. Bob Kane, Sr. Vice President of Clinical Services for NAVIX noted "by screening an 'at-risk' population, we are more likely to find individuals in need of treatment than in some other screening programs offered nationwide. Some programs simply take all comers, regardless of age and/or risk factors, often resulting in far less than 5% of individuals in need of further follow up care. Programs that do not yield strong results are seldom repeated. NAVIX clients implementing the VEDI TM program have seen significant disease that would otherwise have gone undetected in their community, and plan to provide screening as an ongoing part of their service."
July 2, 2007 (TAUNTON, MA): - NAVIX recently surpassed the 150,000 annual run-rate for non-invasive vascular procedures. This milestone was achieved by the addition of several new clients over the past 12 months, as well as the significant community outreach and physician marketing programs deployed by NAVIX on behalf of their client base. John Merry, NAVIX' Marketing Manager commented "our clinical strength allows NAVIX to deliver superior diagnostic results. Our focus on marketing to the referring physician communities on behalf our clients has proven a large factor in 'same-store' growth for our clients vascular labs, and something they rely on from NAVIX. Our recent deployment of the Vascular Early Detection Initiative (VEDI TM), a routine risk-focused screening program is a consumer-based outreach program designed to further assist our clients in the identification and diagnosis of at-risk individuals. Clients implementing the VEDI TM program have seen significant disease that would otherwise have gone undetected in their community, and plan to provide screening as an ongoing part of their service."
June 18, 2007 (TAUNTON, MA): - NAVIX is pleased to announce that Joseph (JP) Hughes, Assistant Vice President of Clinical Services for NAVIX Diagnostix was recently published along with his peers in a recent article in the Journal of Vascular Ultrasound. "We are proud to have JP on the team," said Cheryl Ford, NAVIX' President and CEO, "NAVIX is committed to supporting our employees efforts in the ongoing research for the diagnosis of peripheral arterial disease."
May 1, 2007 (PHILADELPHIA, PA): - NAVIX Diagnostix has record month signing three new vascular lab clients. Pennsylvania Vascular Associates, Thomas Jefferson University Physicians, and The Advanced Vein and Vascular Center, Inc. have joined the growing list of NAVIX vascular lab clients. NAVIX Diagnostix, Inc. provides cardiovascular diagnostic services to hospital and physician practices throughout the northeast U.S. "We have built a reputation as a top tier provider of vascular lab services, improving patient care and vascular program revenue and profitability for our clients. Our excellence in delivery combines highly trained vascular technologists with NAVIX' proprietary protocols, delivering studies that speed the critical pathway to patient diagnosis, while reducing many expensive and unnecessary confirmatory diagnostic testing" said Robert Kane, Senior Vice President of Clinical Services for NAVIX. He added, "we are thrilled to have these organizations join the growing list of NAVIX clients."
March 5, 2007 (TAUNTON, MA): - NAVIX Diagnostix announced today that it has launched the a comprehensive risk-focused vascular screening program at a major teaching hospital client site in New York. NAVIX' Vascular Early Detection Initiative (VEDI TM), is a routine, risk-focused screening program aimed at early detection for individuals most at risk for peripheral arterial disease (PAD). It is estimated a that 8-12 million Americans are effected by PAD, including 20% of people over age 65, and those suffering from PAD are 3 times more likely to die of heart attack or stroke. NAVIX was responsible for one of the first ICAVL accredited screening programs deployed in the U.S.
100 Myles Standish Blvd
Taunton, MA 02780
3219 East Tremont Avenue
Bronx, NY 10461
700 Spruce St #101
Philadelphia, PA 19106